SBI Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.6M Sell
12,632
-943
-7% -$956K 0.32% 61
2025
Q4
$14.6M Sell
13,575
-1,618
-11% -$1.55M 0.38% 49
2025
Q3
$11.6M Sell
15,193
-778
-5% -$579K 0.3% 61
2025
Q2
$12.4M Sell
15,971
-1,097
-6% -$852K 0.36% 54
2025
Q1
$14.1M Sell
17,068
-2,899
-15% -$2.41M 0.47% 43
2024
Q4
$15.4M Buy
+19,967
New +$16.5M 0.47% 36

Other funds holding LLY

SBI Securities's LLY Position: Q1 2026 in Review

SBI Securities reduced its Eli Lilly (LLY) stake by 6.9% in Q1 2026, selling an estimated $956K and leaving 12,632 shares worth $11.6M. The position accounts for 0.32% of the portfolio, ranked #61.

SBI Securities first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.4M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SBI Securities held 12,632 shares of Eli Lilly worth $11.6M as of Q1 2026.
  • SBI Securities sold 943 Eli Lilly shares in Q1 2026, an estimated $956K.
  • Eli Lilly made up 0.32% of SBI Securities's portfolio in Q1 2026, its #61 holding.
  • SBI Securities first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Eli Lilly position peaked at $15.4M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.